Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel

Journal of Interventional Cardiac Electrophysiology

Volumn 41, Issue 2, 2014, Pages 117-127

  Panda, Nikhil C ^a   Zuckerman, Sean T ^b   Mesubi, Olurotimi O ^a   Rosenbaum, David S ^a   Penn, Marc S ^c   Donahue, J Kevin ^a   Alsberg, Eben ^a   Laurita, Kenneth R ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Case Western Reserve University   (United States)

^c SUMMA HEALTH SYSTEM   (United States)

Author keywords

Alginate; Biomaterials; Cardiac regeneration; Conduction velocity; Connexin 43; Electrograms; Electrophysiology; Impulse conduction; Impulse propagation; Large animal model; Mesenchymal stem cells; Myocardial infarction; Myocardial scar; Optical mapping; Slow conduction; Stem cell engraftment; Sudden death; Ventricular tachycardia

Indexed keywords

ALGINIC ACID; CONNEXIN 43; GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROGRAPHY; ELECTROSTIMULATION; EX VIVO STUDY; FEMALE; HEART INFARCTION; IMMUNOFLUORESCENCE; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; STERNOTOMY; SWINE; VELOCITY; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CULTURE TECHNIQUE; DISEASE MODEL; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; HEART FUNCTION TEST; HEART MUSCLE CONDUCTION SYSTEM; HYDROGEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; PIG; PROCEDURES; RANDOMIZATION; REFERENCE VALUE; TREATMENT OUTCOME;

ALGINATES; ANALYSIS OF VARIANCE; ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; GLUCURONIC ACID; HEART CONDUCTION SYSTEM; HEXURONIC ACIDS; HYDROGEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROSCOPY, CONFOCAL; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; REFERENCE VALUES; SWINE; TREATMENT OUTCOME;

EID: 84910147412     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-014-9940-9     Document Type: Article

References (44)

1. Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113(10), 1287–1294.
2. Korf-Klingebiel, M., Kempf, T., Sauer, T., Brinkmann, E., Fischer, P., Meyer, G. P., et al. (2008). Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. European Heart Journal, 29(23), 2851–2858.
3. Shiba, Y., Fernandes, S., Zhu, W. Z., Filice, D., Muskheli, V., Kim, J., et al. (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature, 489(7415), 322–325.
4. Wang, D., Zhang, F., Shen, W., Chen, M., Yang, B., Zhang, Y., et al. (2011). Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. International Journal of Cardiology, 152(3), 314–320.
5. Song, H., Hwang, H. J., Chang, W., Song, B. W., Cha, M. J., Kim, I. K., et al. (2011). Cardiomyocytes from phorbol myristate acetate-activated mesenchymal stem cells restore electromechanical function in infarcted rat hearts. Proceedings of the National Academy of Sciences of the United States of America, 108(1), 296–301.
6. Trachtenberg, B., Velazquez, D. L., Williams, A. R., McNiece, I., Fishman, J., Nguyen, K., et al. (2011). Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy [randomized controlled trial]. American Heart Journal, 161(3), 487–493.
7. Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277–2286.
8. Williams, A. R., Trachtenberg, B., Velazquez, D. L., McNiece, I., Altman, P., Rouy, D., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling [clinical trial, phase I]. Circulation Research, 108(7), 792–796.
9. Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., et al. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial [Clinical trial, phase I clinical trial, phase II randomized controlled trial research support, N.I.H., extramural research support, non-U.S. Gov't]. JAMA: The Journal of the American Medical Association, 311(1), 62–73.
10. Mills, W. R., Mal, N., Kiedrowski, M. J., Unger, R., Forudi, F., Popovic, Z. B., et al. (2007). Stem cell therapy enhances electrical viability in myocardial infarction. Journal of Molecular and Cellular Cardiology, 42(2), 304–314.
11. Costa, A. R., Panda, N. C., Yong, S., Mayorga, M. E., Pawlowski, G. P., Fan, K., et al. (2012). Optical mapping of cryoinjured rat myocardium grafted with mesenchymal stem cells. American Journal of Physiology - Heart and Circulatory Physiology, 302(1), H270–H277.
12. Cai, B., Wang, G., Chen, N., Liu, Y., Yin, K., Ning, C., et al. (2014). Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling. Journal of cellular and molecular medicine.
13. Askar, S. F., Ramkisoensing, A. A., Atsma, D. E., Schalij, M. J., de Vries, A. A., & Pijnappels, D. A. (2013). Engraftment patterns of human adult mesenchymal stem cells expose electrotonic and paracrine proarrhythmic mechanisms in myocardial cell cultures [comparative study research support, non-U.S. Gov’t]. Circulation. Arrhythmia and electrophysiology, 6(2), 380–391.
14. Chang, M. G., Tung, L., Sekar, R. B., Chang, C. Y., Cysyk, J., Dong, P., et al. (2006). Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation, 113(15), 1832–1841.
15. Rustad, K. C., Wong, V. W., Sorkin, M., Glotzbach, J. P., Major, M. R., Rajadas, J., et al. (2012). Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials, 33(1), 80–90.
16. Suuronen, E. J., Kuraitis, D., & Ruel, M. (2008). Improving cell engraftment with tissue engineering. Seminars in Thoracic and Cardiovascular Surgery, 20(2), 110–114.
17. Seif-Naraghi, S. B., Singelyn, J. M., Salvatore, M. A., Osborn, K. G., Wang, J. J., Sampat, U., et al. (2013). Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Science Translational Medicine, 5(173), 173ra125.
18. Ifkovits, J. L., Tous, E., Minakawa, M., Morita, M., Robb, J. D., Koomalsingh, K. J., et al. (2010). Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proceedings of the National Academy of Sciences of the United States of America, 107(25), 11507–11512.
19. Sun, J., Li, S. H., Liu, S. M., Wu, J., Weisel, R. D., Zhuo, Y. F., et al. (2009). Improvement in cardiac function after bone marrow cell therapy is associated with an increase in myocardial inflammation. American Journal of Physiology - Heart and Circulatory Physiology, 296(1), H43–H50.
20. Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., Hu, Q., Feigenbaum, G. S., Margitich, I. S., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107(7), 913–922.
21. Alsberg, E., Kong, H. J., Hirano, Y., Smith, M. K., Albeiruti, A., & Mooney, D. J. (2003). Regulating bone formation via controlled scaffold degradation. Journal of Dental Research, 82(11), 903–908.
22. Mills, W. R., Mal, N., Forudi, F., Popovic, Z. B., Penn, M. S., & Laurita, K. R. (2006). Optical mapping of late myocardial infarction in rats. American Journal of Physiology - Heart and Circulatory Physiology, 290(3), H1298–H1306.
23. Fouts, K., Fernandes, B., Mal, N., Liu, J., & Laurita, K. R. (2006). Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm, 3(4), 452–461.
24. Akar, F. G., Yan, G. X., Antzelevitch, C., & Rosenbaum, D. S. (2002). Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome. Circulation, 105(10), 1247–1253.
25. Potapova, I., Plotnikov, A., Lu, Z., Danilo, P. J., Valiunas, V., Qu, J., et al. (2004). Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circulation Research, 94(7), 952–959.
26. Roell, W., Lewalter, T., Sasse, P., Tallini, Y. N., Choi, B. R., Breitbach, M., et al. (2007). Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature, 450(7171), 819–824.
27. Rubart, M., Pasumarthi, K. B., Nakajima, H., Soonpaa, M. H., Nakajima, H. O., & Field, L. J. (2003). Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circulation Research, 92(11), 1217–1224.
28. Pijnappels, D. A., Schalij, M. J., van Tuyn, J., Ypey, D. L., de Vries, A. A., van der Wall, E. E., et al. (2006). Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovascular Research, 72(2), 282–291.
29. Suncion, V. Y., Ghersin, E., Fishman, J. E., Zambrano, J. P., Karantalis, V., Mandel, N., et al. (2014). Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial. Circulation Research, 114(8), 1292–1301.
30. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102(32), 11474–11479.
31. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. Journal of Clinical Investigation, 103(5), 697–705.
32. Rota, M., Kajstura, J., Hosoda, T., Bearzi, C., Vitale, S., Esposito, G., et al. (2007). Bone marrow cells adopt the cardiomyogenic fate in vivo. Proceedings of the National Academy of Sciences of the United States of America, 104(45), 17783–17788.
33. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93–98.
34. Beeres, S. L., Atsma, D. E., van der Laarse, A., Pijnappels, D. A., van Tuyn, J., Fibbe, W. E., et al. (2005). Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. Journal of the American College of Cardiology, 46(10), 1943–1952.
35. Dai, W., Hale, S. L., Martin, B. J., Kuang, J. Q., Dow, J. S., Wold, L. E., et al. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation, 112(2), 214–223.
36. Rose, R. A., Jiang, H., Wang, X., Helke, S., Tsoporis, J. N., Gong, N., et al. (2008). Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells, 26(11), 2884–2892.
37. Haider, H. K. H., Jiang, S., Idris, N. M., & Ashraf, M. (2008). IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circulation Research, 103(11), 1300–1308.
38. Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine, 9(9), 1195–1201.
39. Pedrotty, D. M., Klinger, R. Y., Badie, N., Hinds, S., Kardashian, A., & Bursac, N. (2008). Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. American Journal of Physiology - Heart and Circulatory Physiology, 295(1), H390–H400.
40. Valiunas, V., Doronin, S., Valiuniene, L., Potapova, I., Zuckerman, J., Walcott, B., et al. (2004). Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. The Journal of Physiology, 555(Pt 3), 617–626.
41. Chen, L., Tredget, E. E., Wu, P. Y., & Wu, Y. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 3(4), e1886.
42. Fukushima, S., Varela-Carver, A., Coppen, S. R., Yamahara, K., Felkin, L. E., Lee, J., et al. (2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation, 115(17), 2254–2261.
43. Visage, C. L., Gournay, O., Benguirat, N., Hamidi, S., Chaussumier, L., Mougenot, N., et al. (2012). Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection. Tissue Engineering. Part A, 18(1–2), 35–44.
44. Alsberg, E., Anderson, K. W., Albeiruti, A., Franceschi, R. T., & Mooney, D. J. (2001). Cell-interactive alginate hydrogels for bone tissue engineering. Journal of Dental Research, 80(11), 2025–2029.